ASMPT: Cyclical Recovery Masks Structural Growth, Driven by Advanced Packaging and China OSAT

Core Conclusion

ASMPT's Q1 bookings reached a four-year high, significantly exceeding guidance, while robust Q2 revenue outlook confirms the company is in a strong cyclical upswing. More importantly, this momentum is underpinned by structural growth drivers in AI, advanced packaging, and Chinese EV/OSAT capex, which are not fully reflected in the market's still-cyclical view of the stock. The investment case is transitioning from valuation catch-up to earnings momentum and multiple re-rating potential.

What The Market May Be Missing

The market may be mispricing the quality and sustainability of the current upturn. First, the 72% YoY surge in Q1 bookings and a 1.43 book-to-bill ratio are not merely a function of inventory restocking but reflect robust, multi-pronged end-demand. Second, leadership in Thermal Compression Bonding (TCB), validated by customer adoption in Chip-to-Substrate (C2S) and Chip-to-Wafer (C2W) applications and qualification for HBM4, is a critical, underappreciated driver for long-term growth beyond the traditional wire bonding cycle. Third, the Chinese OSAT capex cycle (forecast +34% in 2026) provides a durable tailwind for its SEMI business that extends the growth runway.

Evidence Chain

Bookings Momentum Confirms a Powerful Inflection. Q1 bookings of US$727m (+46% QoQ, +72% YoY) substantially beat prior guidance of +20%/+40%. The 1.43 book-to-bill ratio is the strongest in recent years, providing exceptional revenue visibility for the coming quarters and signaling a sharp acceleration in demand.

Growth is Broadly Based, Reducing Cyclical Risk. Record SMT bookings were driven by AI servers, optical transceivers, and China EV demand. Simultaneously, SEMI order growth was fueled by demand from Chinese OSATs, high-end smartphones, AI power management, and optics. This diversification across segments and end-markets underscores a structural, not purely cyclical, demand recovery.

TCB Leadership is Transitioning from Validation to Commercialization. In Q1, the company saw sizable shipments and repeat orders for C2S tools and booked four C2W tools. Critically, a key memory player qualified its AOR fluxless process for HBM4 16H. These developments confirm its technology is gaining traction in the most advanced packaging applications, opening a new long-term growth vector.

Forward Guidance Validates Sustained Momentum. Q2 revenue guidance of US$540-600m implies a midpoint growth of +12.2% QoQ and +37.0% YoY, exceeding consensus by ~7%. This outlook, primarily driven by the SEMI segment, demonstrates the company's confidence in converting its strong order book into revenue, de-risking near-term estimates.

Key Risks & Disagreements

The primary risks are a slowdown in global semiconductor demand or a deceleration in Chinese OSAT capital expenditure, which would directly impact the SEMI order cycle. Execution risk in scaling its advanced packaging tools (e.g., hybrid bonding) remains. The ongoing strategic review of the SMT Solutions business introduces uncertainty regarding the future structure and capital allocation of the company.

Valuation & Trade Implication

While the stock price is near the HK$148 target, the fundamental narrative has strengthened. The focus should shift from valuation repair to the execution of growth, with subsequent quarterly revenues likely to surprise consensus positively. A sustained beat-and-raise cycle, coupled with tangible progress in TCB revenue scaling, could drive a re-rating of the stock's multiple as its growth profile is perceived as more structural. Investors should monitor order flow consistency and advanced packaging revenue contribution.